Bank to Report Third Quarter Fiscal 2026 Results Thursday, September 3, 2026 at 7:00 a.m. ETLONDON, ON, Aug. 26, 2026 /CNW/ -- VersaBank (or the "Bank") (TSX:VBNK) (NASDAQ:VBNK) will report its third quarter 2026 financial results and host a conference call to discuss those results on Thursday, September 3, 2026. The conference call/webcast is scheduled for 9:00 a.m. ET and is expected to last approximately 60 minutes. The conference call/webcast will include a presentation by David Taylor, President and Nicolas Ospina, Global CFO, followed by a question-and-answer period. The Bank will report its financial results via news release at approximately 7:00 a.m. ET.
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- VERSABANK TO HOST THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS CONFERENCE CALL/WEBCAST THURSDAY, SEPTEMBER 3 AT 9:00 A.M. ET
- Palladyne AI and NORDA Dynamics to Integrate SwarmOS™ Collaborative Autonomy Software with NORDA’s Combat-Proven Underdog Autonomy Module
Combined Solution Enables Aerial Platforms to Detect, Track and Engage Terrestrial and Maritime Targets, Pairing SwarmOS Edge-Based Perception, Collaboration, and Multi-Target Coordination with NORDA’s Combat-Proven SystemsPalladyne AI (NASDAQ:PDYN), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative autonomy solutions, and NORDA Dynamics ("NORDA"), a Ukrainian-Estonian developer of a drone autonomy ecosystem proven in active combat, today announced a collaboration to integrate Palladyne AI’s SwarmOS™ decentralized, collaborative autonomy platform with the Underdog Autonomy Module, NORDA’s autonomous terminal guidance product for next-generati
- Perion Acquires PRN, a Leading In-Store Retail Media Company with Exclusive Multi-Year Partnerships Across Some of North America’s Largest Retailers
Acquisition accelerates Perion’s In-Store Retail Media DOOH reach and expands Perion’s TAM within the $70B+ U.S. Retail Media Market Perion (NASDAQ & TASE: PERI), an advanced technology leader solving for the complexities of digital advertising through AI-native execution infrastructure, today announced it is accelerating its in-store media presence with the acquisition of PRN, a leading In-Store Retail Media company. The transaction amount is up to $12 million and is expected to be accretive from closing. Physical retail accounts for more than 80% of U.S. retail commerce, and in-store media inventory has become one of the most coveted components of major consumer brands’ media plans, r
- Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference
Insulet Corporation (NASDAQ:PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Wednesday, September 9, 2026, at 2:15 p.m. (Eastern Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insulet Corporation (NASDAQ:PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnip
- Entegris to Host Investor Day on November 9, 2026
Entegris, Inc. (NASDAQ:ENTG), a global leader in advanced materials and purity solutions for the semiconductor industry, today announced it will hold its Investor Day for the investment community in New York City on Monday, November 9, 2026. The event will begin promptly at 1:00pm ET. Scheduled participants will include David Reeder, President and CEO, Sukhi Nagesh, SVP & CFO, as well as additional senior leadership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260825367776/en/ A webcast of the event can also be viewed live on our website at investor.entegris.com. ABOUT ENTEGRIS Entegris is a leading supplier of advanced m
- GUSS Automation, a wholly owned John Deere Subsidiary, Plans to Advance Precision Autonomy in High-Value Crops with Ouster's Next-Generation REV8 Digital Lidar
Unlocking Precision and Safety in Autonomous Agriculture: GUSS Plans Deployment of Rev8 to Revolutionize Orchard Operations Ouster, Inc. (NASDAQ:OUST) ("Ouster" or the "Company"), a leader in sensing and perception for Physical AI, today announced that GUSS Automation, a wholly owned John Deere Subsidiary and a pioneer in autonomous high-value crop operations, plans to incorporate Ouster’s Rev8 OS0 native color digital lidar sensors, powered by the breakthrough L4 Ouster Silicon, into the next generation of its Autonomous Orchard Machine Fleet. The integration is expected to further expand machine capabilities while underscoring the role of advanced sensing technologies in helping autonom
- Photronics Reports Third Quarter 2026 Results
BROOKFIELD, Conn., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Photronics, Inc. (NASDAQ:PLAB), a worldwide leader in photomask technologies and solutions, today reported financial results for its third quarter of fiscal year 2026 ended August 2, 2026. Commenting on the third quarter performance, Chairman and CEO George Macricostas said, "We are pleased to recognize a recovery of some of the temporarily delayed semiconductor design releases that occurred back in our fiscal Q2. Continued high fab utilization rates throughout the industry have been a positive influence toward node migration trends, resulting in a record percentage for our high-end I.C. business at 44% of total I.C. revenue. Our invest
- Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
SYDNEY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, NASDAQ:RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that it has dosed the first patient in the second cohort of its First-In-Human (FIH) Phase 1/2a clinical trial of RV-01 (177Lu-Betabart) in patients with B7-H3 expressing tumors. This follows a positive recommendation from the Safety and Monitoring Committee (SMC), an independent multidisciplinary committee, to advance to the 70 mCi dose of RV-01. RV-01 is a 177Lutetium-tagged engineered monoclonal antibody, des
- Veea and Totalplay Advance Commercial Plans for Secure, AI-Powered Business Services in Mexico
MEXICO CITY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Veea Inc. ("Veea") (NASDAQ:VEEA), a provider of AI-driven, cybersecure edge infrastructure, today announced that its VHC25 VeeaHub® has completed Total Play Telecomunicaciones’ ("Totalplay") technical qualification process, clearing a key milestone as the companies advance plans to offer Veea SecureConnect™ and VigiLynx™ to Totalplay business customers in Mexico. Veea and Totalplay have signed a collaboration agreement that provides a framework for combining Totalplay’s fiber connectivity and managed-services operations with Veea’s cloud-managed edge platform. Totalplay operates one of Mexico’s largest 100% fiber-optic networks and serves re
- TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer
The first patient has been dosed in the TROPION-Urothelial04 phase 3 trial evaluating Datroway® (datopotamab deruxtecan) plus rilvegostomig or Datroway monotherapy versus current standard of care (durvalumab monotherapy or nivolumab monotherapy or enfortumab vedotin plus pembrolizumab) as an adjuvant treatment (after surgery) in patients with muscle invasive urothelial cancer (MIUC) at high risk of recurrence following radical surgical resection with or without prior neoadjuvant therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZe
- Check-Cap Ltd. Announces Pricing of $10 Million Public Offering of Ordinary Shares
ISFIYA, Israel, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ:MBAI), an embodied artificial intelligence company, announced today the pricing of its public offering of 1,538,462 Ordinary Shares at a public offering price of $6.50 per share, before underwriting discounts and commissions. In addition, the Company has granted the underwriter a 30-day option to purchase up to an additional 230,769 Ordinary Shares at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on or about August 27, 2026, subject to the satisfaction of customary closing conditions. The gross proceeds to the Company from
- G-III Apparel Group Announces Date for Second Quarter Fiscal 2027 Results
NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NASDAQ:GIII) today announced that it will release its second quarter fiscal 2027 earnings before the market opens on Wednesday, September 2, 2026. Management will host a conference call to discuss results at 8:30 a.m. ET that same day, followed by a question and answer session for the investment community. To participate via telephone, please register in advance at this link: G-III Apparel Group Second Quarter Fiscal 2027 Earnings Conference Call. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique pa
- Auddia Announces LT350 CEO to be Interviewed on Fox Business’ Varney & Co. to Discuss Distributed Datacenter Strategy
A more politically and environmentally durable model for AI datacenter expansion Interview scheduled for today at approximately 9:45 am ET BOULDER, Colo., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) ("Auddia" or the "Company"), an AI-first technology company pursuing a merger to form McCarthy Finney, an AI native operating company, today announced that its CEO, Jeff Thramann, is scheduled to be interviewed this morning, August 26th at approximately 9:45 am EST (subject to potential change) on Fox Business' Varney & Co. The interview will focus on LT350’s distributed parking lot canopy network as an alternative to AI mega centers as AI continues to transition from the trai
- Sling TV Teams Up with Nine College Football Standouts to Help Fans Watch Football on Their Terms This Season
ENGLEWOOD, Colo., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Sling TV, the most flexible live streaming service, today announced a new nationwide name, image, and likeness (NIL) campaign, teaming up with nine standout college football players to help fans "Watch Football on YOUR Terms" throughout the 2026 season. Athletes who are defining their own paths on the field will help share Sling’s commitment to giving fans the ultimate flexibility to watch sports from wherever they are. With flexible 1-day, 3-day, and 7-day pass subscriptions, affordable monthly packages, and even a season-long plan, Sling makes it easier for fans to catch the college football matchups they want, without overpaying
- Senmiao Technology Limited Announces Name Change to Valor Energy Inc.
New York, NY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Senmiao Technology Limited. (NASDAQ:AIHS) ("AIHS" or the "Company"), an emerging digital infrastructure, energy and strategically emerging industries company, is pleased to announce that it has changed its name to "Valor Energy Inc" after receiving the Certificate of Amendment on Change of Name from the Secretary of State of the State of Nevada, on August 18, 2026. The change of name will be effective on Nasdaq on August 26, 2026. The Company’s common stock of par value $0.0001 per share, will continue trading on the Nasdaq Capital Market under the trading symbol "VAI", replacing the previous symbol "AIHS" and the CUSIP number shall remain
- Reynolds Consumer Products to Participate in Barclays 19th Annual Global Consumer Conference
Reynolds Consumer Products Inc. (the "Company") (NASDAQ:REYN) announced that President and Chief Executive Officer, Scott Huckins, and Chief Financial Officer, Nathan Lowe, will participate in a fireside chat at the Barclays 19th Annual Global Consumer Conference on Wednesday, September 9, 2026, at 3:45 p.m. ET.The fireside chat will be webcast live and can be accessed on the "Events & Presentations" section of the Company’s website at https://investors.reynoldsconsumerproducts.com/. A replay of the webcast will be available following the event.About Reynolds Consumer Products Inc.Reynolds Consumer Products is a leading provider of household essentials designed to simplify daily life, so con
- Electra and Ontario Advance North America’s Critical Minerals Future with $17.5 Million Funding Agreement
TORONTO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ:ELBM, TSXV:ELBM) ("Electra" or the "Company") is pleased to announce that it has finalized definitive agreements with Invest Ontario, an agency of the Government of Ontario, for C$17.5M in previously announced funding to support construction of its cobalt sulfate refinery in Temiskaming Shores, Ontario. "We are grateful to Invest Ontario and the Government of Ontario for their continued partnership on this strategic asset," said Trent Mell, CEO of Electra. "We are focused on completing North America’s first cobalt sulfate refinery and creating the long term employment and economic activities that come
- Ligand to Participate in September Investor Conferences
JUPITER, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced its senior management team will participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference 2026 (Boston): Management will participate in a fireside chat at 12:45 p.m. ET on September 8, 2026.Citi 2026 Biopharma Back to School Conference (New York): Management will participate in a fireside chat at 9:20 a.m. ET on September 10, 2026.H.C. Wainwright 28th Annual Global Investment Conference (New York): Management will present on September 14, 2026 at 10:00 a.m. ET. Ligand management is scheduled to host one-on-one meetings with investors and a
- INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEBFilings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained through approval, may provide regulatory incentives and 10 years of market exclusivity BOCA RATON, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) ("INmune Bio" or the "Company"), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has submitted two regulatory packages to the European Medicines Agency (EMA) for Ebstrocel™: an application for Orphan Drug Designation and a Scientific Advice package to streamline the upcoming Mar
- Sound Group Inc. Reports Unaudited Financial Results for the First Half 2026
SINGAPORE, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Sound Group Inc. (NASDAQ:SOGP) ("SOGP" or the "Company" or "We"), a global AI-powered audio company, today announced its unaudited financial results for the six months ended June 30, 2026. First Half 2026 Financial and Operational Highlights Net revenues were RMB1,690.6 million (US$249.2 million), representing a 25% increase from RMB1,357.7 million for the same period last year.Net income was RMB120.5 million (US$17.8 million), representing a 78% increase from RMB67.6 million for the same period last year. Mr. Jinnan (Marco) Lai, Founder and CEO of SOGP, commented, "We delivered another solid performance in the first half of 2026, with net re